Market Tracker

06/27 3:00pm ET

Cytokinetics Inc (NASDAQ:CYTK)

13.58
Delayed Data
As of 2:45pm ET
 -0.325 / -2.34%
Today’s Change
8.51
Today|||52-Week Range
17.20
+11.73%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close13.90
Today’s open13.91
Day’s range13.40 - 13.95
Volume322,900
Average volume (3 months)663,774
Market cap$676.6M
Dividend yield--
Data as of 2:45pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-738.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio169.7
Price/Sales4.86
Price/Book5.99

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.63+2.54%
DEPODepomed Inc-0.10-0.91%
VSARVersartis Inc-0.70-3.68%
FLXNFlexion Therapeutics...-0.83-3.82%
Data as of 3:00pm ET, 06/27/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts